Shasun plans new facility in VisakhapatnamIllustrative image – not actual.

Shasun Chemicals is likely to set up an Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh, at an investment of Rs 100 crore by 2012.

Initially, the company will be investing Rs 35 crore in the API plant which will be further upped in future.

Besides, the company also launched its drug 'Streptokinase' injections, used in the cardio vascular segment which marked its foray into bioequivalence segment. It has collaborated with Lupin Pharmaceuticals and Alembic for marketing the drug in India.

← All latest storiesBack to top →